Home › Funds › Parkman Healthcare Partners LLC › CYRX
Parkman Healthcare Partners LLC position in CYRX
CRYOPORT INC · Health Care
Parkman Healthcare Partners LLC reported holding 678,568 shares of CYRX (CRYOPORT INC) in its Q3 2026 13F filing — a position valued at US$11.8M, representing 1.07% of its reported portfolio and ranking #38 among its reported holdings. Parkman Healthcare Partners LLC has disclosed CYRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's CYRX position evolved
Parkman Healthcare Partners LLC first disclosed a stake in CYRX in Q2 2026 at 508,324 shares (US$8.0M). The position peaked in Q3 2026 at 678,568 shares, worth US$11.8M. Across 2 filings, Parkman Healthcare Partners LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 678,568 shares valued at US$11.8M — an increase of 170,244 shares quarter over quarter.. Notable position changes include a 33% increase in Q3 2026 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 508.32K | $7.98M | New |
| Q3 2026 | 678.57K | $11.81M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYRX and 13F data
CYRX (CRYOPORT INC) is a Health Care company. 44 other funds we track also report a position in CYRX — the largest reported positions include CADIAN CAPITAL MANAGEMENT, LP (US$42.1M), MAK CAPITAL ONE LLC (US$20.1M), Meros Investment Management, LP (US$11.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYRX
- CADIAN CAPITAL MANAGEMENT, LP 2.42M sh · $42.09M · Q3 2026
- MAK CAPITAL ONE LLC 1.28M sh · $20.05M · Q2 2026
- Meros Investment Management, LP 743.31K sh · $11.67M · Q2 2026
- BROWN CAPITAL MANAGEMENT LLC 601.92K sh · $10.47M · Q3 2026
- Intrinsic Edge Capital Management LLC 564.28K sh · $9.82M · Q3 2026
- Lionhunter Capital Management, LLC 478.64K sh · $8.33M · Q3 2026
- Roubaix Capital, LLC 454.93K sh · $7.92M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held CYRX?
Parkman Healthcare Partners LLC has disclosed CYRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Parkman Healthcare Partners LLC's current position in CYRX?
As of Q3 2026, Parkman Healthcare Partners LLC holds 678.57K shares of CYRX (CRYOPORT INC), valued at $11.81M, representing 1.07% of its reported portfolio and ranking #38.
Has Parkman Healthcare Partners LLC been buying or selling CYRX?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in CYRX. The position peaked in Q3 2026 at 678.57K shares.
Which other funds hold CYRX?
Other major institutional holders of CYRX include CADIAN CAPITAL MANAGEMENT, LP, MAK CAPITAL ONE LLC, Meros Investment Management, LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.